Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H16ClNO2S.H2O4S |
Molecular Weight | 419.9 |
Optical Activity | ( + ) |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O.COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=CC=CC=C3Cl
InChI
InChIKey=FDEODCTUSIWGLK-RSAXXLAASA-N
InChI=1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4)/t15-;/m0./s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
PLAVIX (AUTHORIZED: ATRIAL FIBRILLATION)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL TEVA (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PLAVIX (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL TEVA (AUTHORIZED: STROKE)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
NCI_THESAURUS |
C80483
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL ZENTIVA (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZYLLT (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PLAVIX (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL TEVA (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZYLLT (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZYLLT (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL-BMS (WITHDRAWN: ACUTE CORONARY SYNDROME)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ZYLLT (AUTHORIZED: STROKE)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL ZENTIVA (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ISOCOVER (AUTHORIZED: ATRIAL FIBRILLATION)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ISCOVER (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL RATIOPHARM (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DUOCOVER (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL ZENTIVA (AUTHORIZED: STROKE)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL-BMS (WITHDRAWN: STROKE)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DUOPLAVIN (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL ZENTIVA (AUTHORIZED: PERIPHERAL VASCULAR DISEASES)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PLAVIX (AUTHORIZED: STROKE)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL/ACETYLSALICYLIC ACID (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL-BGR (AUTHORIZED: STROKE)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL-BMS (WITHDRAWN: PERIPHERAL VASCULAR DISEASES)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DUOPLAVIN (AUTHORIZED: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL BMS (WITHDRAWN: MYOCARDIAL INFARCTION)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL RATIOPHARM (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL/ACETYLSALICYCLIC ACID TEVA (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CLOPIDOGREL RATIOPHARM (AUTHORIZED: STROKE)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
DUOCOVER (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ISCOVER (AUTHORIZED: ACUTE CORONARY SYNDROME)
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
120202-66-6
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
PRIMARY | |||
|
m3655
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
PRIMARY | Merck Index | ||
|
236991
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
PRIMARY | RxNorm | ||
|
100000092025
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
PRIMARY | |||
|
CHEMBL1771
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
PRIMARY | |||
|
3759
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
PRIMARY | |||
|
08I79HTP27
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
PRIMARY | |||
|
SUB12483MIG
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
PRIMARY | |||
|
08I79HTP27
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
PRIMARY | |||
|
135046-48-9
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
DTXSID601016080
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
PRIMARY | |||
|
C2673
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
PRIMARY | |||
|
1140430
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
PRIMARY | |||
|
115366
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
PRIMARY | |||
|
DBSALT000029
Created by
admin on Fri Dec 15 15:37:34 UTC 2023 , Edited by admin on Fri Dec 15 15:37:34 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD